ilShinbiobase Co. Ltd (068330) — Financial Flexibility Index
ilShinbiobase Co. Ltd (068330) has a Financial Flexibility Index of 0.48x as of March 2026. Free cash flow of ₩3.50 Billion (operating CF ₩3.46 Billion minus capex ₩38.55 Million) represents 0% of total liabilities (₩7.33 Billion). For the full cash flow conversion analysis, see 068330 cash generation efficiency.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ilShinbiobase Co. Ltd Financial Flexibility Index (2014–2025)
Historical Financial Flexibility Index trend for ilShinbiobase Co. Ltd across 12 annual periods. Check 068330 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Financial Flexibility Index for ilShinbiobase Co. Ltd (2014–2025)
Year-by-year free cash flow to debt coverage for ilShinbiobase Co. Ltd. Check how aggressively does ilShinbiobase Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | ₩5.29 Billion | ₩5.27 Billion | ₩3.79 Billion | ▲ +16.7% |
| 2024 | 1.20x | ₩4.17 Billion | ₩4.12 Billion | ₩3.49 Billion | ▼ -31.3% |
| 2023 | 1.74x | ₩6.19 Billion | ₩5.92 Billion | ₩3.55 Billion | ▲ +154.4% |
| 2022 | 0.68x | ₩3.17 Billion | ₩2.65 Billion | ₩4.63 Billion | ▼ -36.8% |
| 2021 | 1.08x | ₩6.88 Billion | ₩6.74 Billion | ₩6.36 Billion | ▲ +3.7% |
| 2020 | 1.04x | ₩5.40 Billion | ₩4.50 Billion | ₩5.17 Billion | ▼ -1.5% |
| 2019 | 1.06x | ₩5.79 Billion | ₩5.55 Billion | ₩5.47 Billion | ▼ -23.2% |
| 2018 | 1.38x | ₩5.26 Billion | ₩4.88 Billion | ₩3.81 Billion | ▲ +78.9% |
| 2017 | 0.77x | ₩2.52 Billion | ₩2.11 Billion | ₩3.27 Billion | ▲ +9.9% |
| 2016 | 0.70x | ₩3.28 Billion | ₩3.01 Billion | ₩4.68 Billion | ▲ +906.0% |
| 2015 | 0.07x | ₩369.60 Million | ₩270.22 Million | ₩5.30 Billion | ▼ -92.0% |
| 2014 | 0.87x | ₩3.43 Billion | ₩3.33 Billion | ₩3.93 Billion | — |